Qingqiang Zeng

1.1k total citations · 1 hit paper
12 papers, 899 citations indexed

About

Qingqiang Zeng is a scholar working on Molecular Biology, Orthopedics and Sports Medicine and Rheumatology. According to data from OpenAlex, Qingqiang Zeng has authored 12 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Orthopedics and Sports Medicine and 4 papers in Rheumatology. Recurrent topics in Qingqiang Zeng's work include Bone Metabolism and Diseases (6 papers), Bone health and osteoporosis research (5 papers) and Bone health and treatments (3 papers). Qingqiang Zeng is often cited by papers focused on Bone Metabolism and Diseases (6 papers), Bone health and osteoporosis research (5 papers) and Bone health and treatments (3 papers). Qingqiang Zeng collaborates with scholars based in United States, China and Hong Kong. Qingqiang Zeng's co-authors include Yanfei Li, Henry U. Bryant, Kyle M. Sousa, Christina N. Bennett, Kurt D. Hankenson, Venkatesh Krishnan, Timothy F. Lane, Isabelle Gerin, Hongjiao Ouyang and Ormond A. MacDougald and has published in prestigious journals such as PLoS ONE, Biomaterials and Endocrinology.

In The Last Decade

Qingqiang Zeng

12 papers receiving 879 citations

Hit Papers

3D-bioprinted BMSC-laden biomimetic multiphasic scaffolds... 2021 2026 2022 2024 2021 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingqiang Zeng United States 11 536 370 301 134 127 12 899
Toshinori Ishizuya Japan 13 640 1.2× 426 1.2× 284 0.9× 94 0.7× 134 1.1× 21 1.0k
Yasuto Taguchi United States 10 668 1.2× 431 1.2× 180 0.6× 172 1.3× 214 1.7× 10 1.1k
Val Mann United Kingdom 5 340 0.6× 187 0.5× 296 1.0× 136 1.0× 77 0.6× 8 665
Qing Zeng United States 15 330 0.6× 236 0.6× 260 0.9× 143 1.1× 49 0.4× 22 763
Konosuke Nakayama Japan 9 337 0.6× 204 0.6× 141 0.5× 83 0.6× 97 0.8× 13 625
Nathan A. Wigner United States 13 316 0.6× 153 0.4× 137 0.5× 102 0.8× 90 0.7× 17 738
Ryotaro Iwasaki Japan 14 587 1.1× 381 1.0× 159 0.5× 50 0.4× 218 1.7× 21 1.0k
Fumitaka Ichida Japan 6 585 1.1× 175 0.5× 72 0.2× 101 0.8× 173 1.4× 7 839
Ann‐Kristin Picke Germany 12 273 0.5× 133 0.4× 194 0.6× 49 0.4× 48 0.4× 14 609
Séverine Couillaud France 10 414 0.8× 376 1.0× 98 0.3× 36 0.3× 107 0.8× 12 682

Countries citing papers authored by Qingqiang Zeng

Since Specialization
Citations

This map shows the geographic impact of Qingqiang Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingqiang Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingqiang Zeng more than expected).

Fields of papers citing papers by Qingqiang Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingqiang Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingqiang Zeng. The network helps show where Qingqiang Zeng may publish in the future.

Co-authorship network of co-authors of Qingqiang Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Qingqiang Zeng. A scholar is included among the top collaborators of Qingqiang Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingqiang Zeng. Qingqiang Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Meng, Xiangbo, Ling Li, Cuishan Huang, et al.. (2023). Anti-inflammatory and anabolic biphasic scaffold facilitates osteochondral tissue regeneration in osteoarthritic joints. Journal of Material Science and Technology. 156. 20–31. 10 indexed citations
2.
Li, Ling, Cuishan Huang, Qingqiang Zeng, et al.. (2022). Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway. Journal of Orthopaedic Translation. 33. 55–69. 23 indexed citations
3.
Liu, Yanzhi, Liuqi Peng, Lingli Li, et al.. (2021). 3D-bioprinted BMSC-laden biomimetic multiphasic scaffolds for efficient repair of osteochondral defects in an osteoarthritic rat model. Biomaterials. 279. 121216–121216. 139 indexed citations breakdown →
4.
Cheng, Wenxiang, Donghao Gan, Yiping Hu, et al.. (2021). The effect and mechanism of QufengZhitong capsule for the treatment of osteoarthritis in a rat model. Journal of Orthopaedic Translation. 28. 65–73. 11 indexed citations
5.
Li, Ling, Cuishan Huang, Jiani Wang, et al.. (2020). Qu Feng Zhi Tong capsule increases mechanical properties of cortical bone in ovariectomised rats. Journal of Orthopaedic Translation. 25. 115–124. 4 indexed citations
6.
Irizarry, Armando R., Guirui Yan, Qingqiang Zeng, et al.. (2017). Defective enamel and bone development in sodium-dependent citrate transporter (NaCT) Slc13a5 deficient mice. PLoS ONE. 12(4). e0175465–e0175465. 40 indexed citations
7.
Bennett, Christina N., Hongjiao Ouyang, Yanfei Li, et al.. (2007). Wnt10b Increases Postnatal Bone Formation by Enhancing Osteoblast Differentiation. Journal of Bone and Mineral Research. 22(12). 1924–1932. 230 indexed citations
8.
Li, Yanfei, Qingqiang Zeng, David W. Donley, et al.. (2006). Teriparatide Increases Bone Formation in Modeling and Remodeling Osteons and Enhances IGF-II Immunoreactivity in Postmenopausal Women With Osteoporosis. Journal of Bone and Mineral Research. 21(6). 855–864. 170 indexed citations
9.
Kulkarni, Nalini H., Jude E. Onyia, Qingqiang Zeng, et al.. (2006). Orally Bioavailable GSK-3α/β Dual Inhibitor Increases Markers of Cellular Differentiation In Vitro and Bone Mass In Vivo. Journal of Bone and Mineral Research. 21(6). 910–920. 150 indexed citations
10.
Li, Yanfei, Henry U. Bryant, Qingqiang Zeng, et al.. (2005). Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats. Journal of Bone and Mineral Metabolism. 23(S1). 62–68. 13 indexed citations
11.
Li, Yanfei, Henry U. Bryant, Qingqiang Zeng, et al.. (2003). New Bone Formation with Teriparatide [Human Parathyroid Hormone-(1–34)] Is Not Retarded by Long-Term Pretreatment with Alendronate, Estrogen, or Raloxifene in Ovariectomized Rats. Endocrinology. 144(5). 2008–2015. 75 indexed citations
12.
Li, Yanfei, Henry U. Bryant, Qingqiang Zeng, et al.. (2002). Long-Term Dosing of Arzoxifene Lowers Cholesterol, Reduces Bone Turnover, and Preserves Bone Quality in Ovariectomized Rats. Journal of Bone and Mineral Research. 17(12). 2256–2264. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026